Targeting CD155 by rediocide-A overcomes tumour immuno-resistance to natural killer cells
Context Therapeutic benefits of immunotherapy are restricted by cancer immune-resistance mechanisms. Rediocide-A (Red-A), a natural product extracted from Traditional Chinese Medicine, is a promising agent to battle against cancer which acts as an immune checkpoint inhibitor. Objective To investigat...
Saved in:
Main Authors: | Wanyi Ng (Author), Chenyuan Gong (Author), Xuewei Yan (Author), Guifan Si (Author), Chen Fang (Author), Lixin Wang (Author), Xiaowen Zhu (Author), Zihang Xu (Author), Chao Yao (Author), Shiguo Zhu (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Ancient Chinese Decoction Yu-Ping-Feng Suppresses Orthotopic Lewis Lung Cancer Tumor Growth Through Increasing M1 Macrophage Polarization and CD4+ T Cell Cytotoxicity
by: Lixin Wang, et al.
Published: (2019) -
A high-throughput assay for screening natural products that boost NK cell-mediated killing of cancer cells
by: Zihang Xu, et al.
Published: (2020) -
Generating Anti-TIGIT and CD155 Monoclonal Antibodies for Tumor Immunotherapy
by: Yu-Hang Duan, et al.
Published: (2022) -
NK Cell-Dependent Growth Inhibition of Lewis Lung Cancer by Yu-Ping-Feng, an Ancient Chinese Herbal Formula
by: Yingbin Luo, et al.
Published: (2016) -
Concepts for agonistic targeting of CD40 in immuno-oncology
by: David M. Richards, et al.
Published: (2020)